FACTOID # 28: Mexico has the most Jehovah's Witnesses per capita in the OECD.
 
 Home   Encyclopedia   Statistics   Countries A-Z   Flags   Maps   Education   Forum   FAQ   About 
 
 
 
WHAT'S NEW
RELATED ARTICLES
People who viewed "Erythropoietin" also viewed:
RECENT ARTICLES
More Recent Articles »
 

SEARCH ALL

FACTS & STATISTICS    Advanced view

Search encyclopedia, statistics and forums:

 

 

(* = Graphable)

 

 


Encyclopedia > Erythropoietin
erythropoietin
Identifiers
Symbol(s) EPO
Entrez 2056
OMIM 133170
RefSeq NM_000799
UniProt P01588
Other data
Locus Chr. 7 q21

Erythropoietin (IPA pronunciation: [ɪˌɹɪθ.ɹoˈpo.ɪ.tɪn], alternative pronunciations: [ɪˌrɪθroʊˈpɔɪtn, əˌrɪθroʊ-, əˌriθroʊ-]) or EPO is a glycoprotein hormone that is a cytokine for erythrocyte (red blood cell) precursors in the bone marrow. Also called hematopoietin or hemopoietin, it is produced by the kidney, and is the hormone regulating red blood cell production. Erythropoietin is available as a therapeutic agent produced by recombinant DNA technology in mammalian cell culture. It is used in treating anemia resulting from chronic renal failure or from cancer chemotherapy. Its use is also believed to be common as a blood doping agent in endurance sports such as bicycle racing, triathlons and marathon running. Image File history File links Download high resolution version (1008x684, 81 KB) Erythropoietin Created with data set from Protein Data Bank and the free program Rasmol. ... Hugo is a masculine name. ... The Entrez logo The Entrez Global Query Cross-Database Search System allows access to databases at the National Center for Biotechnology Information (NCBI) website. ... The Mendelian Inheritance in Man project is a database that catalogues all the known diseases with a genetic component, and - when possible - links them to the relevant genes in the human genome. ... The National Center for Biotechnology Information (NCBI) is part of the US National Library of Medicine (NLM), which is a branch of the US National Institutes of Health. ... Swiss-Prot is a curated biological database of protein sequences created in 1986 by Amos Bairoch during his PhD and developed by the Swiss Institute of Bioinformatics and the European Bioinformatics Institute. ... Short and long arms Chromosome. ... Chromosome 7 is one of the 23 pairs of chromosomes in humans. ... For information on how to read IPA transcriptions of English words see here. ... A glycoprotein is a macromolecule composed of a protein and a carbohydrate (an oligosaccharide). ... Norepinephrine A hormone (from Greek όρμή - to set in motion) is a chemical messenger from one cell (or group of cells) to another. ... Cytokines is a group of proteinaceous signalling compounds that like hormones and neurotransmitters are used extensively for inter-cell communication. ... Human red blood cells Red blood cells are the most common type of blood cell and are the vertebrate bodys principal means of delivering oxygen to body tissues via the blood. ... Human red blood cells Red blood cells are the most common type of blood cell and the vertebrate bodys principal means of delivering oxygen from the lungs or gills to body tissues via the blood. ... Grays Anatomy illustration of cells in bone marrow. ... Recombinant DNA technology adds/replaces DNA in an organism resulting in the recipient organism containing exogenous DNA. Recombinant proteins are proteins that are produced by different genetically modified organisms following insertion of the relevant DNA into their genome. ... Epithelial cells in culture, stained for keratin (red) and DNA (green) Cell culture is the term applied when cells are grown in a synthetic environment. ... Anemia (AmE) or anaemia (BrE), from the Greek () meaning without blood, refers to a deficiency of red blood cells (RBCs) and/or hemoglobin. ... Cancer is a class of diseases or disorders characterized by uncontrolled division of cells and the ability of these cells to spread, either by direct growth into adjacent tissue through invasion, or by implantation into distant sites by metastasis (where cancer cells are transported through the bloodstream or lymphatic system). ... Chemotherapy is the use of chemical substances to treat disease. ... Blood doping is the practice of illicitly boosting the number of red blood cells (RBCs) in the circulation in order to enhance athletic performance. ... Bicycle racing encompasses many forms in which bicycles are used for competition. ... A triathlon is a Greek word that refers to an athletic event made up of three contests. ... Modern day marathon runners The word marathon refers to a long-distance road running event of 42. ...

Contents

Discovery and biological role

The existence of a humoral factor regulating red blood cell production was first postulated in 1906 based on transfusion experiments in rabbits. In 1950, the still unidentified erythropoietic factor was found to be stimulated in rats breathing a low-oxygen atmosphere, thus establishing the elements of its biological regulation. In the 1960s its source was identified as the kidneys. Human EPO was first purified from human urine by T. Miyake, C. K. Kung and E. Goldwasser at the University of Chicago in 1977. Limited quantitites of the native human protein were used experimentally to treat patients with anemia. Human red blood cells Red blood cells are the most common type of blood cell and the vertebrate bodys principal means of delivering oxygen from the lungs or gills to body tissues via the blood. ... 1906 (MCMVI) was a common year starting on Monday (see link for calendar). ... 1950 (MCML) was a common year starting on Sunday (link will take you to calendar). ... Erythropoiesis is the process by which red blood cells (erythrocytes) are produced. ... It has been suggested that Renal anomalies and Renal plasma threshold be merged into this article or section. ... The University of Chicago is a private university located principally in the Hyde Park neighborhood of Chicago. ... For the album by Ash, see 1977 (album). ... Anemia (AmE) or anaemia (BrE), from the Greek () meaning without blood, refers to a deficiency of red blood cells (RBCs) and/or hemoglobin. ...


EPO has now been identified as a glycoprotein with a molecular mass of about 30,000 Daltons. It has a 165 amino acid chain with four oligosaccharide side chains and circulates in the blood plasma at a very low concentration (about 5 pmol/L). A glycoprotein is a macromolecule composed of a protein and a carbohydrate (an oligosaccharide). ... The molecular mass (abbreviated MM) of a substance, formerly also called molecular weight and abbreviated as MW, is the mass of one molecule of that substance, relative to the unified atomic mass unit u (equal to 1/12 the mass of one atom of carbon-12). ... The unified atomic mass unit (u), or Dalton (Da), is a small unit of mass used to express atomic and molecular masses. ... Phenylalanine is one of the standard amino acids. ... An oligosaccharide is a saccharide polymer containing a small number (typically three to six) of component sugars, also known as simple sugars. ... Blood plasma is the liquid component of blood, in which the blood cells are suspended. ... The mole (symbol: mol) is the SI base unit that measures an amount of substance. ... The litre or liter (U.S. spelling, see spelling differences) is a unit of volume. ...


In adult humans, EPO is produced primarily by peritubular cells in the kidneys, where its production is stimulated by low oxygen levels in the blood, also known as hypoxia. Some EPO is also produced by the liver, which is the primary source in the fetus. It has been suggested that Renal anomalies and Renal plasma threshold be merged into this article or section. ... General Name, Symbol, Number oxygen, O, 8 Chemical series Nonmetals, chalcogens Group, Period, Block 16, 2, p Appearance colorless (gas) very pale blue (liquid) Atomic mass 15. ... Human blood smear: a - erythrocytes; b - neutrophil; c - eosinophil; d - lymphocyte. ... Hypoxia is a pathological condition in which the body as a whole (generalised hypoxia) or region of the body (tissue hypoxia) is deprived of adequate oxygen supply. ... The liver is an organ in some animals, including vertebrates (and therefore humans). ... A human fetus A fetus (or foetus, or fœtus – see below) is a developing mammal after the embryonic stage and before birth. ...


EPO acts by binding to a specific erythropoietin receptor (EpoR) on the surface of red cell precursors in the bone marrow, stimulating them to transform into mature red blood cells. As a result the oxygen level in blood reaching the kidney rises and the amount of EPO produced decreases. In biochemistry, a receptor is a protein on the cell membrane or within the cytoplasm or cell nucleus that binds to a specific molecule (a ligand), such as a neurotransmitter, hormone, or other substance, and initiates the cellular response to the ligand. ... Grays Anatomy illustration of cells in bone marrow. ... Human red blood cells Red blood cells are the most common type of blood cell and the vertebrate bodys principal means of delivering oxygen from the lungs or gills to body tissues via the blood. ... General Name, Symbol, Number oxygen, O, 8 Chemical series Nonmetals, chalcogens Group, Period, Block 16, 2, p Appearance colorless (gas) very pale blue (liquid) Atomic mass 15. ...


Because the kidneys are the primary source of erythropoietin, chronic kidney disease often results in a systemic deficiency of EPO and consequent anemia. Anemia can also occur in cancer patients, sometimes as a direct result of the malignancy but usually as an adverse effect of chemotherapy. Chronic renal failure (CRF, or chronic kidney failure, CKF, or chronic kidney disease, CKD) is a slowly progressive loss of renal function over a period of months or years and defined as an abnormally low glomerular filtration rate, which is usually determined indirectly by the creatinine level in blood serum. ... Anemia (AmE) or anaemia (BrE), from the Greek () meaning without blood, refers to a deficiency of red blood cells (RBCs) and/or hemoglobin. ... Chemotherapy is the use of chemical substances to treat disease. ...


Also, in patients who may require a blood transfusion or undergo surgery where blood loss is expected, EPO is given in advance as a precaution. The bone marrow produces more red blood cells, and if blood is lost during the operation, there is still enough to sustain the patient. Donating blood Blood transfusion is the process of transferring blood or blood-based products from one person into the circulatory system of another. ... Grays Anatomy illustration of cells in bone marrow. ...


EPO as a therapeutic agent

Therapeutic human EPO was initially isolated and purified from urine in 1977. In 1983, the gene coding for EPO was identified. In 1991 it was also approved for treating anemia resulting from cancer chemotherapy.Johnson & Johnson, an American pharmaceutical company, markets EPO under license from Amgen for cancer chemotherapy under the brand name Procrit. EPO is generally injected under the skin by the patient, although it may also be given intravenously. Several injections weekly are required for the original forms, but the long-acting forms may require injections only once every two weeks.By far the most common side-effect for any EPO products is fever. Also, use of EPO products can lead to an increased chance of the formation of blood clots. Headache, nausea, vomiting, and delirium are also common side-effects. All forms of EPO are expensive. A dialysis patient, who can expect to require lifelong EPO treatment, will pay up to $10,000 per year for the drug in the U.S. Cancer chemotherapy patients, who require EPO for shorter periods, pay about $1,000 per month in the U.S. Worldwide revenues for sales of EPO were over 'USD$10 billion in 2004.'


EPO as a blood doping agent

Although pharmaceutical EPO has benefited many thousands of anemic patients, it also has a converse side as a blood doping agent sometimes used by healthy athletes to gain a competitive advantage. By increasing the oxygen carrying capacity of the blood it increases the aerobic respiratory capacity of the muscles, making it appealing to participants in endurance sports such as cycling and long-distance running. It is considered to be especially valuable in multi-stage bicycle races, where it can offset the decrease in red blood cells that occurs over several weeks of racing. EPO doping probably became common in Grand Tour cycling after pharmaceutical EPO became available in the late 1980s, but there was at the time no way to prove its use in the absence of physical evidence of EPO possession. The deaths of a dozen or more elite cyclists in the early 1990s from heart failure while sleeping, were grim evidence of its overuse. Excessive use of pharmaceutical EPO can lead to so many red blood cells that the blood becomes thick enough to strain the heart, especially during sleep when the heart rate is low. Beyond a certain point, the increase in haematocrit is actually detrimental to the oxygen carrying capacity due to negative blood flow effects, and increases the likelihood of developing symptoms similar to chronic mountain sickness.The extent of the doping problem became undeniable after the Festina team scandal in the 1998 Tour de France, in which Willy Voet, was apprehended with a huge cache of doping materials, including EPO. He and others later wrote about the widespread use of drugs in cycling. In the 2000 Tour de France, a laboratory test to detect residues of pharmaceutical EPO in urine was introduced for the first time as an anti-doping measure. It was developed by the French National Laboratory for Doping Detection. The test method relies on laboratory methods for distinguishing pharmaceutical EPO from the endogenous EPO normally present in an athlete’s urine after strenuous exercise. Because existing brands of pharmaceutical EPO are made in cell culture animal cells, they have a different pattern of residues than the native human form. Although widely applied, the test is controversial. In 2005, Rutger Beke, a Belgian triathlete successfully challenged his conviction for EPO doping by presenting scientific evidence that the test was unreliable in his case. Several other athletes have since made similar defenses. In the highest profile case to date, Spanish rider Roberto Heras was stripped of what would have been his fourth win of the Vuelta a España in 2005 after a positive urine test for pharmaceutical EPO. He has asserted his innocence and vowed to challenge the conviction based on the handling of his sample and alleged weaknesses in the test method.


Erythropoietin and Jehovah's Witnesses

Jehovah's Witnesses believe in the Bible's command at Acts 15:28,29 to "abstain from blood"; this belief results in the refusal to accept transfusions of whole blood or any of its four major components.


The use of erythropoietin to increase the number of red blood cells is one suggested alternative to a blood transfusion.


The presence of human albumin in the erythropoietin mixture may preclude its use by some Jehovah's Witnesses, although an alternative now exists: Darbepoetin alfa (marketed under the name Aranesp), a synthetic form of erythropoietin containing no blood fractions. Darbepoetin alfa (rINN) (IPA: ) is a synthetic form of erythropoietin. ...


Adverse effects

Erythropoietin is associated with an increased risk of adverse cardiovascular complications if it is used to increase hemoglobin levels above 13.0 g/dl.[1] 3-dimensional structure of hemoglobin. ...


See also

Amgen Inc. ... Previous forms of synthetic EPO were detectable because they were produced in non-human cells (i. ... Shire Pharmaceuticals Group plc is a British manufacturer of pharmaceuticals including Adderall XR, Carbatrol, and Fosrenol. ... Blood doping is the practice of illicitly boosting the number of red blood cells (RBCs) in the circulation in order to enhance athletic performance. ... The Watch Tower Bible and Tract Society of Pennsylvania is the main legal entity used by Jehovah’s Witnesses. ...

References

  1. ^ Drüeke TB, Locatelli F, Clyne N, et al. (2006). "Normalization of hemoglobin level in patients with chronic kidney disease and anemia" 355 (20): 2071–84. 
  • Miyake T, Kung CK, Goldwasser E. Purification of human erythropoietin. J Biol Chem. 1977 Aug 10;252(15):5558-64.

External links


  Results from FactBites:
 
Erythropoietin - Wikipedia, the free encyclopedia (1129 words)
Erythropoietin (or EPO) is a glycoprotein hormone that is a growth factor for erythrocyte (red blood cell) precursors in the bone marrow.
Because the kidneys are the primary source of erythropoietin, chronic renal failure often results in deficiency, and consequently a hypoplastic anemia.
Erythropoietin is also sometimes given in advance of a surgical operation for patients who cannot or do not wish to receive blood transfusions, such as Jehovah's Witnesses, in an attempt to increase the body's red blood count to an extent sufficient to counteract possible blood loss during the operation without requiring a transfusion.
  More results at FactBites »


 
 

COMMENTARY     


Share your thoughts, questions and commentary here
Your name
Your comments

Want to know more?
Search encyclopedia, statistics and forums:

 


Lesson Plans | Student Area | Student FAQ | Reviews | Press Releases |  Feeds | Contact
The Wikipedia article included on this page is licensed under the GFDL.
Images may be subject to relevant owners' copyright.
All other elements are (c) copyright NationMaster.com 2003-5. All Rights Reserved.
Usage implies agreement with terms, 1022, m